Happy Saturday! Welcome to Ask D’Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. This week, Wil offers some thoughts on burning questions about people with diabetes (PWDs) being able to take to the skies as pilots, and whether losing weight is a “cure” for those with type 2. There might even be a Frank Sinatra reference in there…
{Got your own questions? Email us at AskDMine@diabetesmine.com}
Amit…
Read more »
By
AmyT on
January 17, 2012
In case you haven’t heard, famous butter-and-cream Southern supreme chef Paula Deen has announced that she is a type 2 diabetic… and that she has partnered with Novo Nordisk in a campaign promoting their drug, Victoza. The way the Internet is all abuzz with this news, you’d think President Obama had been diagnosed with diabetes. But apparently the fact that Paula Deen, renowned for her carb-laden cookbooks and television shows, now has type 2 diabetes…
Read more »
It always sounds like losing weight should be simple, right? Just eat smart and exercise regularly. Yet it’s so much more darn difficult than it sounds! The Mayo Clinic Diet was recently named one of the best diets by U.S. News and World Report, and now the same editors of that New York Times Bestseller have released The Mayo Clinic Diabetes Diet, designed specifically for people with type 2 diabetes (although type 1 diabetics can…
Read more »
Type 2 diabetes is a sneaky beast, and often has been hiding in the background for far longer than people realize. So for many people, the diagnosis of type 2 diabetes also comes along with diagnosis of a complication.
This is what happened to Mike Durbin. When he was diagnosed with type 2 diabetes in 2008, he was also diagnosed with heart disease. He was also only 27 years old! He immediately had to reverse…
Read more »
The world of type 2 diabetes drugs is wacky indeed. While Amylin’s long-acting version of Byetta — called Bydureon and predicted by many experts to become a blockbuster — is still held up at FDA, the agency approved a new oral drug earlier this month that is reportedly unremarkable except in the lawsuit it has spurred.
The drug is called linagliptin, brand name Tradjenta, a new oral DPP-4 inhibitor from Eli Lilly and Boehringer that…
Read more »
